These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6232241)
21. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Schlick E; Ruffmann R; Wiltrout RH; Chirigos MA Cancer Res; 1985 Mar; 45(3):1058-65. PubMed ID: 3155990 [TBL] [Abstract][Full Text] [Related]
22. The effect of immunomodulation of stimulator antigen presenting cells on subsequent responder T-cell function. Chung SW; Gould B; Dziadkowiecz I; Gorczynski RM Immunol Lett; 1997 Mar; 55(3):133-7. PubMed ID: 9161878 [TBL] [Abstract][Full Text] [Related]
23. Enhanced frequency of mitogen-responsive T cell precursors in old mice injected with thymosin alpha 1. Frasca D; Adorini L; Doria G Eur J Immunol; 1987 May; 17(5):727-30. PubMed ID: 3495446 [TBL] [Abstract][Full Text] [Related]
24. Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin. Dziarski R J Immunol; 1989 Jul; 143(1):356-65. PubMed ID: 2471741 [TBL] [Abstract][Full Text] [Related]
25. Thymosin: an immunomodulator of antibody production in man. Górski A; Korczak-Kowalska G; Nowaczyk M; Gaciong Z; Skopińska-Rózewska E Immunology; 1982 Nov; 47(3):497-501. PubMed ID: 6215339 [TBL] [Abstract][Full Text] [Related]
26. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer. Wang F; Li B; Fu P; Li Q; Zheng H; Lao X Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059 [TBL] [Abstract][Full Text] [Related]
27. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes. Tremblay N; Fontaine P; Perreault C Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709 [TBL] [Abstract][Full Text] [Related]
28. Effect of liposomes on lymphocytes: induction of proliferation of B lymphocytes and potentiation of the cytotoxic response of T lymphocytes to alloantigens. Grover A; Sundharadas G Eur J Immunol; 1986 Jun; 16(6):665-70. PubMed ID: 3487456 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes. Sztein MB; Serrate SA Int J Immunopharmacol; 1989; 11(7):789-800. PubMed ID: 2599716 [TBL] [Abstract][Full Text] [Related]
30. [Specificity of cell-mediated cytotoxicity. II. Cytotoxic lymphocytes after in vitro allogeneic sensitization in the H-2 system]. Schulze HA; Brock J Allerg Immunol (Leipz); 1983; 29(2):100-7. PubMed ID: 6224410 [TBL] [Abstract][Full Text] [Related]
31. Immunostimulation by Alsophila spinulosa extract fraction VII of both humoral and cellular immune responses. Kao SF; Kuo HL; Lee YC; Chiang HC; Lin YS Anticancer Res; 1994; 14(6B):2439-43. PubMed ID: 7872664 [TBL] [Abstract][Full Text] [Related]
32. Immunoregulation in aging. Doria G; Adorini L; Sabbadini E; Mancini C; Frasca D Ann N Y Acad Sci; 1988; 521():182-8. PubMed ID: 2897816 [No Abstract] [Full Text] [Related]
33. Functional characteristics of T cell receptors during sensitization against histocompatibility antigens in vitro. Kimura AK; Clark WR Cell Immunol; 1974 Apr; 12(1):127-39. PubMed ID: 4282067 [No Abstract] [Full Text] [Related]
34. Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). Talmage DW; Woolnough JA; Hemmingsen H; Lopez L; Lafferty KJ Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4610-4. PubMed ID: 303772 [TBL] [Abstract][Full Text] [Related]
35. The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice. Dullens HF; Vuist W; Van der Maas M; Den Otter W Cancer Immunol Immunother; 1986; 23(2):113-8. PubMed ID: 3536093 [TBL] [Abstract][Full Text] [Related]
36. Cyclic nucleotide changes in murine lymphocytes following thymosin incubation in vitro. Naylor PH; Thurman GB; Goldstein AL Immunopharmacology; 1979 Mar; 1(2):89-101. PubMed ID: 233584 [TBL] [Abstract][Full Text] [Related]
37. Responsiveness of T cells to mutant major histocompatibility complex class I antigen. II. Role of stimulator-type accessory cells with reference to interleukin 1 production. Watanabe H; Saitoh T; Fujiwara M Scand J Immunol; 1989 Mar; 29(3):343-51. PubMed ID: 2524093 [TBL] [Abstract][Full Text] [Related]
38. Antigenically activated helper T cells are required as stimulator cells for optimal activation of cytotoxic T lymphocytes under conditions of limiting helper factors. Moyers C; Droege W Cell Immunol; 1983 Jan; 75(1):1-12. PubMed ID: 6218891 [TBL] [Abstract][Full Text] [Related]
39. Restimulation of cytolytic T-lymphocytes in long-term mixed leukocyte cultures. 1. Physical and proliferative characteristics of cytolytic T-lymphocytes restimulated at low cell density. MacDonald HR Cell Immunol; 1978 Feb; 35(2):414-26. PubMed ID: 145901 [No Abstract] [Full Text] [Related]
40. Thymosin-induced differentiation of murine thymocytes in allogeneic mixed lymphocyte cultures. Cohen GH; Hopper JA; Goldstein AL Ann N Y Acad Sci; 1975 Feb; 249():145-53. PubMed ID: 165764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]